LivingGLP1
Study S001100

Wegovy® (Semaglutide) Database Study: A Population-based Cohort Study to Investigate Safety Outcomes of Exposure to Wegovy During Pregnancy

Registration

Registration
NCT05503927
Study type
OBSERVATIONAL
Status
ENROLLING_BY_INVITATION
Enrollment
2701
Start
2020-02-01
Primary completion
2027-08-15
Lead sponsor
Novo Nordisk A/S
Conditions
Pregnancy; Obesity; Overweight
Interventions
OTHER:No Intervention
Results posted
FALSE
Individual participant data sharing
YES
Secondary identifiers
OTHER:U1111-1273-4411

Registered primary outcomes

  • Number of Infants with Major Congenital Malformation (MCM) [Birth up to 1 year of age]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.